Perla Giles, a rising senior majoring in molecular microbiology, and David Lee, a rising senior majoring in chemistry, both ...

Stanford researchers have developed a technology that delivers RNA to damaged neurons and stimulates regrowth – paving the ...

Qi and his colleagues used a version of the gene-editing tool CRISPR, called CRISPR-Cas13, to target individual pieces of RNA (unlike the more widely known CRISPR-Cas9, which targets DNA).

Stanford's CRISPR-TO tech enables precise RNA delivery in neurons, offering breakthrough treatment potential for ALS, spinal injuries, and neurodegenerative diseases.

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access information on a device and to provide personalised ads and content, ad and ...

CRISPR Therapeutics has begun realizing sales on Casgevy, its first therapy and a joint venture with Vertex Pharmaceuticals. The company has plenty of cash to fund research and development for the ...

An appeals court has opened another chapter in the long-running CRISPR patent saga. Three years after a patent body ruled in favor of the teams behind Editas Medicine’s intellectual property ...

Last August, KJ Muldoon was born with a potentially fatal genetic disorder. Just six months later, he received a Crispr treatment designed just for him. Muldoon has a rare disorder known as CPS1 ...